Abound Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
172
+26
| +18% | +$2.87K | 0.01% | 339 |
|
|
2025
Q1 | $16.3K | Sell |
146
-49
| -25% | -$5.47K | 0.01% | 331 |
|
|
2024
Q4 | $18K | Sell |
195
-170
| -47% | -$15.7K | 0.01% | 295 |
|
|
2024
Q3 | $30.6K | Buy |
365
+183
| +101% | +$15.4K | 0.01% | 227 |
|
|
2024
Q2 | $12.5K | Sell |
182
-25
| -12% | -$1.72K | ﹤0.01% | 331 |
|
|
2024
Q1 | $15.2K | Sell |
207
-38
| -16% | -$2.79K | 0.01% | 301 |
|
|
2023
Q4 | $19.8K | Buy |
245
+45
| +23% | +$3.64K | 0.01% | 264 |
|
|
2023
Q3 | $15K | Buy |
200
+2
| +1% | +$150 | 0.01% | 263 |
|
|
2023
Q2 | $15.3K | Buy |
198
+31
| +19% | +$2.4K | 0.01% | 265 |
|
|
2023
Q1 | $13.9K | Buy |
167
+28
| +20% | +$2.33K | 0.01% | 249 |
|
|
2022
Q4 | $12K | Buy |
139
+42
| +43% | +$3.61K | 0.01% | 240 |
|
|
2022
Q3 | $6K | Buy |
+97
| New | +$6K | ﹤0.01% | 340 |
|